ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,633.91
      0.00%
      US Tech 100
      20,132.80
      0.07%
      Dow Jones
      39,721.36
      0.00%
      Brent Oil
      84.555
      -0.58%
      Bitcoin
      58,767.44
      1.75%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Hutchmed (china) Limited (HCM)

      7. Hutchmed (china) Limited (HCM) News

      HCM

      Hutchmed (china) (HCM)

      Hutchmed (china) Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:HCM
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      12:30PMiHub NewswireFeaturedECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch
      12/14/20212:00AMRNS Non-RegulatoryHutchmed (China) Limited HMPL-523 Clinical Data Presented at ASHLSE:HCMHutchmed (china) Limited
      12/10/20214:59AMRNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Presents Data at ESMO Immuno-Oncology '21LSE:HCMHutchmed (china) Limited
      12/06/20215:44AMAlliance NewsAlliance NewsHutchmed completes patient enrolment for cancer drug studyLSE:HCMHutchmed (china) Limited
      12/06/20212:00AMRNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Completes Planned Enrollment of FRESCO-2LSE:HCMHutchmed (china) Limited
      12/03/20214:54AMAlliance NewsAlliance NewsTwo Hutchmed drugs included on China's state approved medicines listLSE:HCMHutchmed (china) Limited
      12/03/20212:00AMUK RegulatoryHutchmed (China) Limited Updated NRDL to include ELUNATE and SULANDALSE:HCMHutchmed (china) Limited
      11/30/20213:29AMUK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
      11/24/20216:35AMAlliance NewsAlliance NewsHutchmed China shares rise on Orphathys and Tagrisso Phase 3 studyLSE:HCMHutchmed (china) Limited
      11/24/20212:00AMRNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and AZ Initiate SACHI Phase 3 TrialLSE:HCMHutchmed (china) Limited
      11/19/20219:54AMPR Newswire (US)Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewingLSE:HCMHutchmed (china) Limited
      11/11/20218:35AMPR Newswire (US)International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on November 16th and 17th, 2021LSE:HCMHutchmed (china) Limited
      11/08/20212:00AMRNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Present Clinical Data at ASHLSE:HCMHutchmed (china) Limited
      11/01/20215:14AMAlliance NewsAlliance NewsTOP NEWS: Astra transfers drug rights to Covis in USD270 million dealLSE:HCMHutchmed (china) Limited
      11/01/20213:10AMAlliance NewsAlliance News*Hutchmed and AstraZeneca begin study of renal cell carcinoma drug savolitinibLSE:HCMHutchmed (china) Limited
      11/01/20213:00AMRNS Non-RegulatoryHutchmed (China) Limited HUTCHMED and AZ Initiate SAMETA Global P3 TrialLSE:HCMHutchmed (china) Limited
      10/29/20214:30AMUK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
      10/28/20214:59PMAlliance NewsAlliance NewsIN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drugLSE:HCMHutchmed (china) Limited
      10/28/20212:00AMRNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase III Trial of HMPL-523LSE:HCMHutchmed (china) Limited
      10/20/20214:30AMUK RegulatoryHutchmed (China) Limited Grant of Awards under Long Term Incentive PlanLSE:HCMHutchmed (china) Limited
      09/30/20214:29AMUK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:HCMHutchmed (china) Limited
      09/29/20216:08AMAlliance NewsAlliance NewsHutchmed China sells joint venture stake for USD169 millionLSE:HCMHutchmed (china) Limited
      09/29/20212:00AMRNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Highlights Presentations at CSCO 2021LSE:HCMHutchmed (china) Limited
      09/29/20212:00AMRNS Non-RegulatoryHutchmed (China) Limited Closure of Non-Core OTC Joint Venture DivestmentLSE:HCMHutchmed (china) Limited
      09/21/20215:51AMAlliance NewsAlliance NewsHutchmed starts drug combination trial for neuroendocrine tumoursLSE:HCMHutchmed (china) Limited
      09/21/20212:00AMRNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase III Trial SURTORI-01LSE:HCMHutchmed (china) Limited
      09/20/20214:09AMAlliance NewsAlliance NewsHutchmed starts Japan trial for surufatinib in neuroendocrine tumorsLSE:HCMHutchmed (china) Limited
      09/20/20212:00AMRNS Non-RegulatoryHutchmed (China) Limited Japan Bridging Study For Surufatinib InitiatedLSE:HCMHutchmed (china) Limited
      09/13/20215:22AMAlliance NewsAlliance NewsHutchmed China's amdizalisib secures breakthrough therapy designationLSE:HCMHutchmed (china) Limited
       Showing the most relevant articles for your search:LSE:HCM

      Your Recent History

      USOTC
      BBKCF
      Bigg Digital Assets (QX)
      Delayed Upgrade Clock